Literature DB >> 11726157

Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice.

S Alvarez1, C Herrero, E Bru, G Perdigon.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that rarely causes pulmonary disease in normal hosts but one that is an important cause of acute pneumonia in immunocompromised patients, including neonates, and of chronic pneumonia in patients with cystic fibrosis. The aim of this work was to study the effect of oral administration of Lactobacillus casei and yogurt on prevention of P. aeruginosa lung infection in young mice (3 weeks old). This study demonstrates that oral administration of L. casei or yogurt to young mice enhanced lung clearance of P. aeruginosa and phagocytic activity of alveolar macrophages through a dose-dependent effect. There were, however, no significant differences in white blood cell (WBC) differential counts. Furthermore, it was observed that previous administration of L. casei or yogurt induced a significant increase in IgA and IgM levels in bronchoalveolar lavages (BALs) after a P. aeruginosa infection, although there was no relationship with the serum values.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726157     DOI: 10.4315/0362-028x-64.11.1768

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  22 in total

1.  A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.

Authors:  Shahram Lavasani; Balik Dzhambazov; Mehrnaz Nouri; Frida Fåk; Sophia Buske; Göran Molin; Henrik Thorlacius; Jan Alenfall; Bengt Jeppsson; Björn Weström
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

2.  Immunomodulatory Effects of Lactobacillus plantarum on Inflammatory Response Induced by Klebsiella pneumoniae.

Authors:  Marjolaine Vareille-Delarbre; Sylvie Miquel; Sophie Garcin; Thomas Bertran; Damien Balestrino; Bertrand Evrard; Christiane Forestier
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

3.  Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia.

Authors:  Ludmila Khailova; Christine H Baird; Aubri A Rush; Christopher Barnes; Paul E Wischmeyer
Journal:  Clin Nutr       Date:  2016-10-01       Impact factor: 7.324

Review 4.  Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials.

Authors:  Zeinab Nikniaz; Leila Nikniaz; Nemat Bilan; Mohammad Hossein Somi; Elnaz Faramarzi
Journal:  World J Pediatr       Date:  2017-04-29       Impact factor: 2.764

Review 5.  Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections.

Authors:  Marcela Medina; Elisa Vintiñi; Julio Villena; Raul Raya; Susana Alvarez
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

6.  Enhancement in ex vivo phagocytic capacity of peritoneal leukocytes in mice by oral delivery of various lactic-acid-producing bacteria.

Authors:  Yeonhee Lee; Taik-Soo Lee
Journal:  Curr Microbiol       Date:  2004-12-08       Impact factor: 2.188

7.  Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.

Authors:  E Vintiñi; J Villena; S Alvarez; M Medina
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

Review 8.  Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.

Authors:  Juliette C Madan
Journal:  Clin Ther       Date:  2016-03-10       Impact factor: 3.393

Review 9.  The influence of the microbiome on respiratory health.

Authors:  Tomasz P Wypych; Lakshanie C Wickramasinghe; Benjamin J Marsland
Journal:  Nat Immunol       Date:  2019-09-09       Impact factor: 25.606

Review 10.  Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.

Authors:  Marina Gomes Machado; Valentin Sencio; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.